About PhotoPharmics
PhotoPharmics is a company based in American Fork (United States) founded in 2011.. PhotoPharmics has raised $43.44 million across 11 funding rounds from investors including HHS, Kickstart Fund and Kickstart Fund. PhotoPharmics offers products and services including Celeste Specialized Phototherapy and Light-for-PD Clinical Trial. PhotoPharmics operates in a competitive market with competitors including Cala Health, Civitas Therapeutics, Sapiens Neuro, Charco Neurotech and Aleva Neuro, among others.
- Headquarter American Fork, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Photopharmics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$43.44 M (USD)
in 11 rounds
-
Latest Funding Round
$6 M (USD), Series B
Apr 21, 2025
-
Investors
HHS
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PhotoPharmics
PhotoPharmics offers a comprehensive portfolio of products and services, including Celeste Specialized Phototherapy and Light-for-PD Clinical Trial. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive device for treating Parkinson's symptoms at home.
Remote trial platform for testing phototherapy efficacy in patients.
Unlock access to complete
Unlock access to complete
Advisor Team
7 people
Leadership Team
2 people
Sales and Marketing
2 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of PhotoPharmics
PhotoPharmics has successfully raised a total of $43.44M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $6 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series B — $6.0M
-
First Round
First Round
(14 Nov 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series B - PhotoPharmics | Valuation | Kickstart Fund |
|
| Sep, 2024 | Amount | Grant - PhotoPharmics | Valuation |
investors |
|
| Oct, 2023 | Amount | Series B - PhotoPharmics | Valuation | Kickstart Seed Fund |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PhotoPharmics
PhotoPharmics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Kickstart Fund and Kickstart Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed investments are provided to Mountain West startups since 2008.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to early-stage startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PhotoPharmics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PhotoPharmics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Photopharmics Comparisons
Competitors of PhotoPharmics
PhotoPharmics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cala Health, Civitas Therapeutics, Sapiens Neuro, Charco Neurotech and Aleva Neuro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable neuromodulation devices for essential tremor relief are developed.
|
|
| domain | founded_year | HQ Location |
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
|
|
| domain | founded_year | HQ Location |
Developer of brain stimulation device to treat neurodegenerative disorders
|
|
| domain | founded_year | HQ Location |
Non-invasive wearable devices for Parkinson's management are developed.
|
|
| domain | founded_year | HQ Location |
Implantable deep brain stimulation systems are developed for neurological diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Photopharmics
Frequently Asked Questions about PhotoPharmics
When was PhotoPharmics founded?
PhotoPharmics was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is PhotoPharmics located?
PhotoPharmics is headquartered in American Fork, United States. It is registered at American Fork, Utah, United States.
Is PhotoPharmics a funded company?
PhotoPharmics is a funded company, having raised a total of $43.44M across 11 funding rounds to date. The company's 1st funding round was a Series B of $23.88M, raised on Nov 14, 2012.
What does PhotoPharmics do?
Founded in 2011 and based in American Fork, United States, PhotoPharmics operates in the medical device sector, focusing on phototherapy solutions. Non-invasive light therapy is developed as an adjunct to drug treatments for Parkinsons disease. Improvements in symptoms have been observed in prior investigations. A pivotal study on safety and efficacy is currently underway at sites in Amsterdam, Boston, and Salt Lake City.
Who are the top competitors of PhotoPharmics?
PhotoPharmics's top competitors include Cala Health, Aleva Neuro and Charco Neurotech.
What products or services does PhotoPharmics offer?
PhotoPharmics offers Celeste Specialized Phototherapy and Light-for-PD Clinical Trial.
Who are PhotoPharmics's investors?
PhotoPharmics has 3 investors. Key investors include HHS, Kickstart Fund, and Kickstart Fund.